Citadel Advisors
KALA icon

Citadel Advisors’s KALA BIO KALA Stock Holding History

Citadel Advisors’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,633
Closed -$48.8K – 14318
2026
Q1 		$48.8K Buy
5,633
+4,505
+399% +$95.3K ﹤0.01% 12410
2025
Q4 		$31.3K Buy
+1,128
New +$50.5K ﹤0.01% 12215
2024
Q2 		– Sell
-269
Closed -$106K – 14888
2024
Q1 		$106K Buy
+269
New +$99.9K ﹤0.01% 11280
2022
Q4 		– Sell
-53
Closed -$30K – 15189
2022
Q3 		$30K Sell
53
-16
-23% -$12.6K ﹤0.01% 11908
2022
Q2 		$52K Buy
69
+38
+123% +$59.6K ﹤0.01% 11914
2022
Q1 		$108K Sell
31
-12
-28% -$31.4K ﹤0.01% 12212
2021
Q4 		$130K Sell
43
-1
-2% -$4.64K ﹤0.01% 12448
2021
Q3 		$289K Buy
44
+34
+340% +$293K ﹤0.01% 11126
2021
Q2 		$133K Buy
10
+1
+11% +$15.7K ﹤0.01% 12636
2021
Q1 		$145K Sell
9
-23
-72% -$449K ﹤0.01% 12088
2020
Q4 		$545K Buy
32
+21
+191% +$395K ﹤0.01% 7973
2020
Q3 		$212K Buy
+11
New +$253K ﹤0.01% 8714
2020
Q2 		– Sell
-99
Closed -$2.8M – 10173
2020
Q1 		$2.18M Buy
99
+46
+87% +$735K ﹤0.01% 4004
2019
Q4 		$489K Sell
53
-47
-47% -$454K ﹤0.01% 6832
2019
Q3 		$948K Buy
100
+42
+72% +$511K ﹤0.01% 5692
2019
Q2 		$921K Buy
58
+19
+49% +$315K ﹤0.01% 5821
2019
Q1 		$802K Sell
39
-25
-39% -$444K ﹤0.01% 5987
2018
Q4 		$786K Buy
+64
New +$1.11M ﹤0.01% 5683

Other funds holding KALA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Citadel Advisors's KALA Position: Q2 2026 in Review

Citadel Advisors sold out of KALA BIO (KALA) in Q2 2026, closing a stake of 5,633 shares — an estimated $48.8K sold.

Citadel Advisors first reported a position in KALA in Q4 2018 and held it in 18 quarters. The position peaked at $2.18M in Q1 2020. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

  • Citadel Advisors reported no remaining KALA BIO position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 5,633 KALA BIO shares in Q2 2026, an estimated $48.8K.
  • Citadel Advisors first reported a position in KALA BIO in Q4 2018 and held it in 18 quarters.
  • Citadel Advisors's KALA BIO position peaked at $2.18M in Q1 2020.
  • 14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.